APA (7th ed.) Citation

Valizadeh, A., Fattahi, M. R., Sadeghi, M., Saghab Torbati, M., Sahraian, M. A., & Azimi, A. R. (2022). Disease‐modifying therapies and T1 hypointense lesions in patients with multiple sclerosis: A systematic review and meta‐analysis. CNS Neuroscience & Therapeutics, 28(5), 648. https://doi.org/10.1111/cns.13815

Chicago Style (17th ed.) Citation

Valizadeh, Amir, Mohammad Reza Fattahi, Maryam Sadeghi, Mehrnush Saghab Torbati, Mohammad Ali Sahraian, and Amir Reza Azimi. "Disease‐modifying Therapies and T1 Hypointense Lesions in Patients with Multiple Sclerosis: A Systematic Review and Meta‐analysis." CNS Neuroscience & Therapeutics 28, no. 5 (2022): 648. https://doi.org/10.1111/cns.13815.

MLA (9th ed.) Citation

Valizadeh, Amir, et al. "Disease‐modifying Therapies and T1 Hypointense Lesions in Patients with Multiple Sclerosis: A Systematic Review and Meta‐analysis." CNS Neuroscience & Therapeutics, vol. 28, no. 5, 2022, p. 648, https://doi.org/10.1111/cns.13815.